Table 3 Comparison of the proposed method with previously reported methods.
Analyte | Sample (mg) | Sorbent (mg) | Extraction solventc (mL) | Extraction time (min) | Extraction methoda | Instrumental techniqueb | LOD (ng/ mL) | References |
|---|---|---|---|---|---|---|---|---|
Tanshinone IIA, tanshinone I, cryptotanshinone, dihydrotanshinone, salvianolic acid B | Danshen and its preparations, 500 mg | — | 70% methanol, 20 mL | 20 | UAE | LC-DAD | 20–140 | |
Protocatechuic acid, protocatechuic aldehyde, caffeic acid, ferulic acid, isoferulic acid, rosmarinic acid, salvianolic acid B, salvianolic acid A, dihydrotanshinone I, przewalskin, cryptotanshinone, tanshinone I, tanshinone IIA | Salvia Miltiorrhiza, 500 mg | — | Methanol, 25 mL | 45 | UAE | UPLC-PDA | 10–350 | |
Danshensu, protocatechuic aldehyde, notoginsenoside R1, ginsenoside Rg1, salvianolic acid B, ginsenoside Rb1, cryptotanshinone, tanshinone IIA | Fufang Danshen preparations, 500 mg | — | 70% methanol, 25 mL | 30 | UAE | HPLC-DAD-ELSD | 40–1290 | |
Tanshinone I, tanshinone IIA, cryptotanshinone | Salvia Miltiorrhiza Bunge, 50 mg | — | 50 mM C16mimBr aqueous solution, 4 mL | 30 | UAE | HPLC-DAD | 10–50 | |
Dihydrotanshinone, cryptotanshinone, tanshinone I, tanshinone IIA, miltirone | Salvia Miltiorrhiza Bunge, 500 mg | — | [C8MIM][PF6] in ethanol, 10 mL | 2 | IL-UPE | HPLC | 8.2–23.1 | |
Danshensu, protocatechuic aldehyde, salvianolic acid B, dihydrotanshinone I, cryptotanshinone, tanshinone I, tanshinoneIIA | Radix salviaemiltiorrhizae, 500 mg | — | 70% methanol in water (v/v), 40 mL | 60 | UAE | HPLC-UV | 6.9–48.7 | |
Danshensu, protocatechuic aldehyde, salvianolic acid B, cryptotanshinone, tanshinone I, tanshinone IIA | Danshen, 30 mg | — | Methanol-Water (80:20, v/v), 4.5 mL | 45 | Shake and sonication | HPLC-PAD | 20–90 | |
Cryptotanshinone, tanshinone I, tanshinone IIA | Salvia Miltiorrhiza Bunge, 500 mg | Ionic liquid-modified silica | Methanol, 50 mL and methanol-acetate acid (90:10,v/v), 2 mL | 240 | SPE | HPLC-UV | 76–93 | |
Salvianolicacid B, lithospermic acid | Danshen tablets, 250 mg | — | Electrolyte solution, 20 mL | 15 | Sonication | MEKC-UV | 100–500 | |
Dihydrotanshinone, tanshinone I, cryptotanshinone, tanshinone IIA | Salvia Miltiorrhiza Bge. root., 10 mg | — | water, 5 mL and [C8MIM][BF4], 0.14 mL | 11 | UA IL-based HLLME | HPLC-UV | 52–93 | |
3-Chlorophenol, 4-chlorophenol, 2,4-dichlorophenols | Water, 50 mL | Graphene nanoplatelets (30 mg) | Methanol, 9 mL; water, 9 mL; 10% (v/v) methanol, 1 mL and alkaline methanol, 2 mL | 50 | SPE | UV-vis spectrophotometry | — | |
Fenpropathrin, cyhalothrin, fenvalerate | Soil, 100 mg | Silica (300 mg) | Acetone, 3 mL; tetrachloroethylene, 50 μL; water, 5 mL | 12 | MSPD-UADLLME | GC-ECD | 0.45–1.13 ng/g | |
Sodium danshensu, protocatechuic aldehyde, rosmarinic acid, lithospermic acid, salvianolic acid B, salvianolic acid A | Danshen tablet, 24 mg | Graphene nanoplatelets (24 mg) | Water, 0.2 mL | 1 | MSPDM | UHPLC-ECD | 1.19–4.62 | This method |
